Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Sebert

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
La Nouvelle Presse Medicale|November 12, 1977
[Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)]J L Sebert, A E Fournier, J Gueris, et al.
Mineral and Electrolyte Metabolism|December 1, 1982
Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretionJ L Sebert, P H Decourcelles, P Morinière, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patientsA Fournier, J L Sebert, P Fohrer, et al.
Presse Medicale (Paris, France : 1983)|April 30, 1988
[High doses of calcium carbonate or the combination of 1 alpha hydroxylated derivatives of vitamin D and aluminum compounds bound to phosphorus in the preventive treatment of renal osteodystrophy]A Fournier, P Morinière, B Boudailliez, et al.
Bone|January 1, 1992
Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?M E Cohen-Solal, J L Sebert, B Boudailliez, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysisJ F de Fremont, J L Sebert, J Gueris, et al.
Bone and Mineral|February 1, 1987
Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patientsJ L Sebert, J C Ruiz, A Fournier, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|November 30, 1991
[Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X-ray computed tomography and histomorphometry]M Audran, P Bataille, J L Sebert, et al.
Presse Medicale (Paris, France : 1983)|March 24, 1984
[Primary hyperparathyroidism. Lack of effect of cimetidine on plasma levels of parathyroid hormone and calcium]D Line, J L Sebert, I Grégoire, et al.
Kidney International. Supplement|February 1, 1986
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremiaA Fournier, P Moriniere, J L Sebert, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
La Nouvelle Presse Medicale|November 12, 1977
[Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)]J L Sebert, A E Fournier, J Gueris, et al.
Mineral and Electrolyte Metabolism|December 1, 1982
Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretionJ L Sebert, P H Decourcelles, P Morinière, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patientsA Fournier, J L Sebert, P Fohrer, et al.
Presse Medicale (Paris, France : 1983)|April 30, 1988
[High doses of calcium carbonate or the combination of 1 alpha hydroxylated derivatives of vitamin D and aluminum compounds bound to phosphorus in the preventive treatment of renal osteodystrophy]A Fournier, P Morinière, B Boudailliez, et al.
Bone|January 1, 1992
Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?M E Cohen-Solal, J L Sebert, B Boudailliez, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysisJ F de Fremont, J L Sebert, J Gueris, et al.
Bone and Mineral|February 1, 1987
Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patientsJ L Sebert, J C Ruiz, A Fournier, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|November 30, 1991
[Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X-ray computed tomography and histomorphometry]M Audran, P Bataille, J L Sebert, et al.
Presse Medicale (Paris, France : 1983)|March 24, 1984
[Primary hyperparathyroidism. Lack of effect of cimetidine on plasma levels of parathyroid hormone and calcium]D Line, J L Sebert, I Grégoire, et al.
Kidney International. Supplement|February 1, 1986
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremiaA Fournier, P Moriniere, J L Sebert, et al.
Pageof 12